Dashboard
Manage Tickers

MRKR


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

marker-therapeutics-reports-2023-net-loss-of-82m-vs-net-loss-of-299m-last-year
Marker Therapeutics Reports 2023 Net Loss ...
03/25/2024 21:56:13

At December 31, 2023, Marker had cash and cash equivalents of $15.1 million. The Company believes that its existing cash and ca...

marker-therapeutics-receives-approval-from-united-states-adopted-name-council-and-international-nonproprietary-names-expert-committee-for-neldaleucel-as-nonproprietary-name-for-mt-601
Marker Therapeutics Receives Approval from...
01/22/2024 12:46:16

cancer-cell-therapy-focused-marker-therapeutics-announces-pipeline-prioritization
Cancer Cell Therapy Focused Marker Therape...
01/08/2024 12:31:07

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its ...

marker-therapeutics-says-multitaa-specific-t-cell-therapies-demonstrate-clinical-safety-and-positive-clinical-data-across-multiple-indications
Marker Therapeutics Says 'MultiTAA-specifi...
01/08/2024 12:30:11

marker-therapeutics-says-strategic-prioritization-of-clinical-programs-with-focus-on-mt-601-in-patients-with-lymphoma
Marker Therapeutics Says 'Strategic priori...
01/08/2024 12:30:04

marker-therapeutics-announces-clinical-program-updates-and-pipeline-prioritization
Marker Therapeutics Announces Clinical Pro...
01/08/2024 12:29:56

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/29/2023 21:31:10

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/11/2023 17:30:56

marker-therapeutics-announces-sustained-complete-response-in-first-lymphoma-patient-treated-with-mt-601-following-car-t-relapse
Marker Therapeutics Announces Sustained Co...
12/11/2023 12:04:24

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

marker-therapeutics-q3-eps-034-up-from-080-yoy-sales-25761k-down-from-395m-yoy
Marker Therapeutics Q3 EPS $(0.34) Up From...
11/10/2023 00:03:53

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses o...

why-is-blood-cancer-focused-marker-therapeutics-stock-trading-higher-today
Why Is Blood Cancer Focused Marker Therape...
09/11/2023 17:46:27

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi...

why-avantax-shares-are-trading-higher-by-over-27-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Avantax Shares Are Trading Higher By O...
09/11/2023 17:38:46

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltuso...

marker-therapeutics-announced-the-preliminary-results-of-the-first-participant-treated-with-mt-601-its-multi-tumor-associated-antigen-specific-t-cell-product-targeting-6-taas-in-the-phase-1-multicenter-apollo-trial
Marker Therapeutics Announced The Prelimin...
09/11/2023 11:04:51

marker-therapeutics-q2-eps-029-up-from-110-yoy-sales-76266k-down-from-79051k-yoy
Marker Therapeutics Q2 EPS $0.29 Up From $...
08/14/2023 20:57:04

Marker Therapeutics (NASDAQ:MRKR) reported quarterly earnings of $0.29 per share. This is a 126.36 percent increase over losses...

marker-therapeutics-announced-non-clinical-data-of-its-lead-multi-tumor-associated-antigen-multitaa-specific-t-cell-product-candidate-mt-401-in-an-off-the-shelf-setting-and-provided-an-update-on-clinical-readiness-for-the-off-the-shelf-program
Marker Therapeutics Announced Non-clinical...
08/07/2023 11:36:47

why-apellis-pharmaceuticals--shares-are-trading-lower-by-around-19-here-are-other-stocks-moving-in-mondays-session
Why Apellis Pharmaceuticals Shares Are Tr...
07/31/2023 19:30:12

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, acc...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
07/31/2023 17:31:28

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
07/28/2023 17:31:12

why-ryanair-holdings-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ryanair Holdings Shares Are Trading Lo...
07/24/2023 18:54:54

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor i...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
07/24/2023 17:31:03

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION